BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31549596)

  • 1. A Novel Highly Selective Cannabinoid CB2 Agonist Reduces in vitro Growth and TGF-beta Release of Human Glial Cell Tumors.
    Cioni C; Tassi M; Marotta G; Mugnaini C; Corelli F; Annunziata P
    Cent Nerv Syst Agents Med Chem; 2019; 19(3):206-214. PubMed ID: 31549596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel CB2 agonist, COR167, potently protects rat brain cortical slices against OGD and reperfusion injury.
    Contartese A; Valoti M; Corelli F; Pasquini S; Mugnaini C; Pessina F; Aldinucci C; Sgaragli G; Frosini M
    Pharmacol Res; 2012 Dec; 66(6):555-63. PubMed ID: 23036353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent immunomodulatory activity of a highly selective cannabinoid CB2 agonist on immune cells from healthy subjects and patients with multiple sclerosis.
    Annunziata P; Cioni C; Mugnaini C; Corelli F
    J Neuroimmunol; 2017 Feb; 303():66-74. PubMed ID: 28041663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoids pharmacological effects are beyond the palliative effects: CB2 cannabinoid receptor agonist induced cytotoxicity and apoptosis in human colorectal cancer cells (HT-29).
    Alenabi A; Malekinejad H
    Mol Cell Biochem; 2021 Sep; 476(9):3285-3301. PubMed ID: 33886060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabichromene is a cannabinoid CB
    Udoh M; Santiago M; Devenish S; McGregor IS; Connor M
    Br J Pharmacol; 2019 Dec; 176(23):4537-4547. PubMed ID: 31368508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CB2 cannabinoid receptor agonist enantiomers HU-433 and HU-308: An inverse relationship between binding affinity and biological potency.
    Smoum R; Baraghithy S; Chourasia M; Breuer A; Mussai N; Attar-Namdar M; Kogan NM; Raphael B; Bolognini D; Cascio MG; Marini P; Pertwee RG; Shurki A; Mechoulam R; Bab I
    Proc Natl Acad Sci U S A; 2015 Jul; 112(28):8774-9. PubMed ID: 26124120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optical Control of Cannabinoid Receptor 2-Mediated Ca
    Sarott RC; Viray AEG; Pfaff P; Sadybekov A; Rajic G; Katritch V; Carreira EM; Frank JA
    J Am Chem Soc; 2021 Jan; 143(2):736-743. PubMed ID: 33399457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of cannabinoid CB
    Salort G; Álvaro-Bartolomé M; García-Sevilla JA
    Psychopharmacology (Berl); 2017 Mar; 234(6):925-941. PubMed ID: 28127623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly potent and selective cannabinoid receptor 2 agonists: initial hit optimization of an adamantyl hit series identified from high-through-put screening.
    Nettekoven M; Fingerle J; Grether U; Grüner S; Kimbara A; Püllmann B; Rogers-Evans M; Röver S; Schuler F; Schulz-Gasch T; Ullmer C
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1177-81. PubMed ID: 23380378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile.
    Gómez-Cañas M; Morales P; García-Toscano L; Navarrete C; Muñoz E; Jagerovic N; Fernández-Ruiz J; García-Arencibia M; Pazos MR
    Pharmacol Res; 2016 Aug; 110():205-215. PubMed ID: 27013280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LPS-mediated neutrophil VEGF-A release is modulated by cannabinoid receptor activation.
    Braile M; Cristinziano L; Marcella S; Varricchi G; Marone G; Modestino L; Ferrara AL; De Ciuceis A; Scala S; Galdiero MR; Loffredo S
    J Leukoc Biol; 2021 Mar; 109(3):621-631. PubMed ID: 32573828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposite changes in cannabinoid CB1 and CB2 receptor expression in human gliomas.
    De Jesús ML; Hostalot C; Garibi JM; Sallés J; Meana JJ; Callado LF
    Neurochem Int; 2010; 56(6-7):829-33. PubMed ID: 20307616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid receptor 2 activation restricts fibrosis and alleviates hydrocephalus after intraventricular hemorrhage.
    Tan Q; Chen Q; Feng Z; Shi X; Tang J; Tao Y; Jiang B; Tan L; Feng H; Zhu G; Yang Y; Chen Z
    Brain Res; 2017 Jan; 1654(Pt A):24-33. PubMed ID: 27769788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Proliferative Properties and Proapoptotic Function of New CB2 Selective Cannabinoid Receptor Agonist in Jurkat Leukemia Cells.
    Capozzi A; Mattei V; Martellucci S; Manganelli V; Saccomanni G; Garofalo T; Sorice M; Manera C; Misasi R
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29973514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cannabinoid CB2 receptor-specific agonist AM1241 increases pentylenetetrazole-induced seizure severity in Wistar rats.
    de Carvalho CR; Hoeller AA; Franco PL; Martini AP; Soares FM; Lin K; Prediger RD; Whalley BJ; Walz R
    Epilepsy Res; 2016 Nov; 127():160-167. PubMed ID: 27608434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression.
    Blázquez C; Salazar M; Carracedo A; Lorente M; Egia A; González-Feria L; Haro A; Velasco G; Guzmán M
    Cancer Res; 2008 Mar; 68(6):1945-52. PubMed ID: 18339876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoids induce glioma stem-like cell differentiation and inhibit gliomagenesis.
    Aguado T; Carracedo A; Julien B; Velasco G; Milman G; Mechoulam R; Alvarez L; Guzmán M; Galve-Roperh I
    J Biol Chem; 2007 Mar; 282(9):6854-62. PubMed ID: 17202146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Switching cannabinoid response from CB(2) agonists to FAAH inhibitors.
    Tourteau A; Leleu-Chavain N; Body-Malapel M; Andrzejak V; Barczyk A; Djouina M; Rigo B; Desreumaux P; Chavatte P; Millet R
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1322-6. PubMed ID: 24508127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting cannabinoid receptor-2 pathway by phenylacetylamide suppresses the proliferation of human myeloma cells through mitotic dysregulation and cytoskeleton disruption.
    Feng R; Tong Q; Xie Z; Cheng H; Wang L; Lentzsch S; Roodman GD; Xie XQ
    Mol Carcinog; 2015 Dec; 54(12):1796-806. PubMed ID: 25640641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Novel Cannabinoid CB2 Receptor Agonists from Botanical Compounds and Preliminary Evaluation of Their Anti-Osteoporotic Effects.
    Hu SJ; Cheng G; Zhou H; Zhang Q; Zhang QL; Wang Y; Shen Y; Lian CX; Ma XQ; Zhang QY; Qin LP
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35163968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.